Molecular Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=806231, encodeId=4bb980623178, content=我的7.3号under review的，现在快5周了，还没有消息，这个杂志一般一审多久，要不要催稿，好担心2个月下去，把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c745395710, createdName=ms2000000533348933, createdTime=Wed Aug 05 08:23:57 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向：分子;肿瘤 经验分享：这杂志也太坑了，一审二审大修小修补实验，历时一年多，提交材料，一句图片问题就拒了，要拒早拒啊，太坑人了，这不是毁人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision，审稿时间两个月，祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=885118, encodeId=864088511849, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：癌症 经验分享：投过两篇个人感觉质量还行但是数量有些欠缺的文章，都被秒拒，心服口服。感觉就是作为高考报志愿里面的平行志愿在试着投，也相当于给自己的论文一个评判的标准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7655403773, createdName=whatever731, createdTime=Mon Sep 14 10:46:50 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927194, encodeId=2d6492e19438, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审3周，三个审稿人，大修两个月时间，目前二审2周，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210225/1e7907b9c6244b9e96e35272db6e4ccb/f320b5ab2f184d5099f752c2eeed24a5.jpg, createdBy=fa002155795, createdName=潇湘1, createdTime=Thu Feb 25 19:05:48 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西)]

2020-08-05 ms2000000533348933

我的7.3号under review的，现在快5周了，还没有消息，这个杂志一般一审多久，要不要催稿，好担心2个月下去，把我拒了

152 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=806231, encodeId=4bb980623178, content=我的7.3号under review的，现在快5周了，还没有消息，这个杂志一般一审多久，要不要催稿，好担心2个月下去，把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c745395710, createdName=ms2000000533348933, createdTime=Wed Aug 05 08:23:57 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向：分子;肿瘤 经验分享：这杂志也太坑了，一审二审大修小修补实验，历时一年多，提交材料，一句图片问题就拒了，要拒早拒啊，太坑人了，这不是毁人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision，审稿时间两个月，祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=885118, encodeId=864088511849, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：癌症 经验分享：投过两篇个人感觉质量还行但是数量有些欠缺的文章，都被秒拒，心服口服。感觉就是作为高考报志愿里面的平行志愿在试着投，也相当于给自己的论文一个评判的标准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7655403773, createdName=whatever731, createdTime=Mon Sep 14 10:46:50 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927194, encodeId=2d6492e19438, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审3周，三个审稿人，大修两个月时间，目前二审2周，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210225/1e7907b9c6244b9e96e35272db6e4ccb/f320b5ab2f184d5099f752c2eeed24a5.jpg, createdBy=fa002155795, createdName=潇湘1, createdTime=Thu Feb 25 19:05:48 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西)]

2022-04-13 H·D·E

4.7 submission 4.12 under review

88 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=806231, encodeId=4bb980623178, content=我的7.3号under review的，现在快5周了，还没有消息，这个杂志一般一审多久，要不要催稿，好担心2个月下去，把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c745395710, createdName=ms2000000533348933, createdTime=Wed Aug 05 08:23:57 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向：分子;肿瘤 经验分享：这杂志也太坑了，一审二审大修小修补实验，历时一年多，提交材料，一句图片问题就拒了，要拒早拒啊，太坑人了，这不是毁人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision，审稿时间两个月，祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=885118, encodeId=864088511849, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：癌症 经验分享：投过两篇个人感觉质量还行但是数量有些欠缺的文章，都被秒拒，心服口服。感觉就是作为高考报志愿里面的平行志愿在试着投，也相当于给自己的论文一个评判的标准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7655403773, createdName=whatever731, createdTime=Mon Sep 14 10:46:50 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927194, encodeId=2d6492e19438, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审3周，三个审稿人，大修两个月时间，目前二审2周，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210225/1e7907b9c6244b9e96e35272db6e4ccb/f320b5ab2f184d5099f752c2eeed24a5.jpg, createdBy=fa002155795, createdName=潇湘1, createdTime=Thu Feb 25 19:05:48 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西)]

2020-07-30 投投投中中中

intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？

142 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=806231, encodeId=4bb980623178, content=我的7.3号under review的，现在快5周了，还没有消息，这个杂志一般一审多久，要不要催稿，好担心2个月下去，把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c745395710, createdName=ms2000000533348933, createdTime=Wed Aug 05 08:23:57 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向：分子;肿瘤 经验分享：这杂志也太坑了，一审二审大修小修补实验，历时一年多，提交材料，一句图片问题就拒了，要拒早拒啊，太坑人了，这不是毁人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision，审稿时间两个月，祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=885118, encodeId=864088511849, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：癌症 经验分享：投过两篇个人感觉质量还行但是数量有些欠缺的文章，都被秒拒，心服口服。感觉就是作为高考报志愿里面的平行志愿在试着投，也相当于给自己的论文一个评判的标准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7655403773, createdName=whatever731, createdTime=Mon Sep 14 10:46:50 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927194, encodeId=2d6492e19438, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审3周，三个审稿人，大修两个月时间，目前二审2周，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210225/1e7907b9c6244b9e96e35272db6e4ccb/f320b5ab2f184d5099f752c2eeed24a5.jpg, createdBy=fa002155795, createdName=潇湘1, createdTime=Thu Feb 25 19:05:48 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西)]

2023-07-26 156GRoK0535(apple) 来自福建省

偏重的研究方向：分子;肿瘤
经验分享：这杂志也太坑了，一审二审大修小修补实验，历时一年多，提交材料，一句图片问题就拒了，要拒早拒啊，太坑人了，这不是毁人吗？

43 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=806231, encodeId=4bb980623178, content=我的7.3号under review的，现在快5周了，还没有消息，这个杂志一般一审多久，要不要催稿，好担心2个月下去，把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c745395710, createdName=ms2000000533348933, createdTime=Wed Aug 05 08:23:57 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向：分子;肿瘤 经验分享：这杂志也太坑了，一审二审大修小修补实验，历时一年多，提交材料，一句图片问题就拒了，要拒早拒啊，太坑人了，这不是毁人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision，审稿时间两个月，祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=885118, encodeId=864088511849, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：癌症 经验分享：投过两篇个人感觉质量还行但是数量有些欠缺的文章，都被秒拒，心服口服。感觉就是作为高考报志愿里面的平行志愿在试着投，也相当于给自己的论文一个评判的标准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7655403773, createdName=whatever731, createdTime=Mon Sep 14 10:46:50 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927194, encodeId=2d6492e19438, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审3周，三个审稿人，大修两个月时间，目前二审2周，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210225/1e7907b9c6244b9e96e35272db6e4ccb/f320b5ab2f184d5099f752c2eeed24a5.jpg, createdBy=fa002155795, createdName=潇湘1, createdTime=Thu Feb 25 19:05:48 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西)]

2021-07-27 145d4029m98暂无昵称

请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。

76 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=806231, encodeId=4bb980623178, content=我的7.3号under review的，现在快5周了，还没有消息，这个杂志一般一审多久，要不要催稿，好担心2个月下去，把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c745395710, createdName=ms2000000533348933, createdTime=Wed Aug 05 08:23:57 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向：分子;肿瘤 经验分享：这杂志也太坑了，一审二审大修小修补实验，历时一年多，提交材料，一句图片问题就拒了，要拒早拒啊，太坑人了，这不是毁人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision，审稿时间两个月，祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=885118, encodeId=864088511849, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：癌症 经验分享：投过两篇个人感觉质量还行但是数量有些欠缺的文章，都被秒拒，心服口服。感觉就是作为高考报志愿里面的平行志愿在试着投，也相当于给自己的论文一个评判的标准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7655403773, createdName=whatever731, createdTime=Mon Sep 14 10:46:50 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927194, encodeId=2d6492e19438, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审3周，三个审稿人，大修两个月时间，目前二审2周，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210225/1e7907b9c6244b9e96e35272db6e4ccb/f320b5ab2f184d5099f752c2eeed24a5.jpg, createdBy=fa002155795, createdName=潇湘1, createdTime=Thu Feb 25 19:05:48 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西)]

2023-07-18 玉米心儿来自上海

今天收到Major revision，审稿时间两个月，祈祷好运。

41 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=806231, encodeId=4bb980623178, content=我的7.3号under review的，现在快5周了，还没有消息，这个杂志一般一审多久，要不要催稿，好担心2个月下去，把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c745395710, createdName=ms2000000533348933, createdTime=Wed Aug 05 08:23:57 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向：分子;肿瘤 经验分享：这杂志也太坑了，一审二审大修小修补实验，历时一年多，提交材料，一句图片问题就拒了，要拒早拒啊，太坑人了，这不是毁人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision，审稿时间两个月，祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=885118, encodeId=864088511849, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：癌症 经验分享：投过两篇个人感觉质量还行但是数量有些欠缺的文章，都被秒拒，心服口服。感觉就是作为高考报志愿里面的平行志愿在试着投，也相当于给自己的论文一个评判的标准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7655403773, createdName=whatever731, createdTime=Mon Sep 14 10:46:50 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927194, encodeId=2d6492e19438, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审3周，三个审稿人，大修两个月时间，目前二审2周，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210225/1e7907b9c6244b9e96e35272db6e4ccb/f320b5ab2f184d5099f752c2eeed24a5.jpg, createdBy=fa002155795, createdName=潇湘1, createdTime=Thu Feb 25 19:05:48 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西)]

2020-09-14 whatever731

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：癌症
经验分享：投过两篇个人感觉质量还行但是数量有些欠缺的文章，都被秒拒，心服口服。感觉就是作为高考报志愿里面的平行志愿在试着投，也相当于给自己的论文一个评判的标准。

2 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=806231, encodeId=4bb980623178, content=我的7.3号under review的，现在快5周了，还没有消息，这个杂志一般一审多久，要不要催稿，好担心2个月下去，把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c745395710, createdName=ms2000000533348933, createdTime=Wed Aug 05 08:23:57 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向：分子;肿瘤 经验分享：这杂志也太坑了，一审二审大修小修补实验，历时一年多，提交材料，一句图片问题就拒了，要拒早拒啊，太坑人了，这不是毁人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision，审稿时间两个月，祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=885118, encodeId=864088511849, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：癌症 经验分享：投过两篇个人感觉质量还行但是数量有些欠缺的文章，都被秒拒，心服口服。感觉就是作为高考报志愿里面的平行志愿在试着投，也相当于给自己的论文一个评判的标准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7655403773, createdName=whatever731, createdTime=Mon Sep 14 10:46:50 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927194, encodeId=2d6492e19438, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审3周，三个审稿人，大修两个月时间，目前二审2周，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210225/1e7907b9c6244b9e96e35272db6e4ccb/f320b5ab2f184d5099f752c2eeed24a5.jpg, createdBy=fa002155795, createdName=潇湘1, createdTime=Thu Feb 25 19:05:48 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西)]

2021-02-25 潇湘1

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：一审3周，三个审稿人，大修两个月时间，目前二审2周，还没有消息

88 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=806231, encodeId=4bb980623178, content=我的7.3号under review的，现在快5周了，还没有消息，这个杂志一般一审多久，要不要催稿，好担心2个月下去，把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c745395710, createdName=ms2000000533348933, createdTime=Wed Aug 05 08:23:57 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向：分子;肿瘤 经验分享：这杂志也太坑了，一审二审大修小修补实验，历时一年多，提交材料，一句图片问题就拒了，要拒早拒啊，太坑人了，这不是毁人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision，审稿时间两个月，祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=885118, encodeId=864088511849, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：癌症 经验分享：投过两篇个人感觉质量还行但是数量有些欠缺的文章，都被秒拒，心服口服。感觉就是作为高考报志愿里面的平行志愿在试着投，也相当于给自己的论文一个评判的标准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7655403773, createdName=whatever731, createdTime=Mon Sep 14 10:46:50 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927194, encodeId=2d6492e19438, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审3周，三个审稿人，大修两个月时间，目前二审2周，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210225/1e7907b9c6244b9e96e35272db6e4ccb/f320b5ab2f184d5099f752c2eeed24a5.jpg, createdBy=fa002155795, createdName=潇湘1, createdTime=Thu Feb 25 19:05:48 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西)]

2023-08-17 1240adaem89暂无昵称来自四川省

想请问一下这个杂志awaiting AE assignment要多久呀？

38 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=806231, encodeId=4bb980623178, content=我的7.3号under review的，现在快5周了，还没有消息，这个杂志一般一审多久，要不要催稿，好担心2个月下去，把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c745395710, createdName=ms2000000533348933, createdTime=Wed Aug 05 08:23:57 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向：分子;肿瘤 经验分享：这杂志也太坑了，一审二审大修小修补实验，历时一年多，提交材料，一句图片问题就拒了，要拒早拒啊，太坑人了，这不是毁人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision，审稿时间两个月，祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=885118, encodeId=864088511849, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：癌症 经验分享：投过两篇个人感觉质量还行但是数量有些欠缺的文章，都被秒拒，心服口服。感觉就是作为高考报志愿里面的平行志愿在试着投，也相当于给自己的论文一个评判的标准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7655403773, createdName=whatever731, createdTime=Mon Sep 14 10:46:50 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927194, encodeId=2d6492e19438, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审3周，三个审稿人，大修两个月时间，目前二审2周，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210225/1e7907b9c6244b9e96e35272db6e4ccb/f320b5ab2f184d5099f752c2eeed24a5.jpg, createdBy=fa002155795, createdName=潇湘1, createdTime=Thu Feb 25 19:05:48 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西)]

2023-07-18 WX631576466 来自广西

审稿速度:3.0 | 投稿命中率:95.0
偏重的研究方向：肿瘤
经验分享：3个月录用接受

37 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务